AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Alameda-based TheraSense, which manufacturers glucose-monitoring equipment, raised $114 million in its initial public offering -- the first Bay Area IPO in two months. The company sold 6 million shares at $19 each in the offering, which had been postponed previously because of poor market conditions. The IPO was managed by an underwriting group led by U.S. …